Personnel Information

写真a

MATSUOKA Yoh


Job title

Visiting Lecturer

Birth date

1972

Mail Address

yoh-m.uro@tmd.ac.jp

Graduating School 【 display / non-display

  • Tokyo Medical and Dental University, Faculty of Medicine, 1997, Graduated

Graduate School 【 display / non-display

  • Tokyo Medical and Dental University, Doctor's Course, 2008.03, Completed

Degree 【 display / non-display

  • Protective effects of heme oxygenase-1 against cyclophosphamide-induced hemorrhagic cystitis in rats, Tokyo Medical and Dental University

Campus Career 【 display / non-display

  • 1997.05
    -
    1998.04
    Tokyo Medical and Dental University, Medical Hospital, Hospital Departments, Departments of Surgery, Urology, Trainee Resident
  • 2001.07
    -
    2001.09
    Tokyo Medical and Dental University, Medical Hospital, Hospital Departments, Departments of Surgery, Urology, Senior Resident
  • 2002.10
    -
    2002.12
    Tokyo Medical and Dental University, Medical Hospital, Hospital Departments, Departments of Surgery, Urology, Senior Resident
  • 2005.04
    -
    2005.09
    Tokyo Medical and Dental University, Medical Hospital, Hospital Departments, Departments of Surgery, Urology, Senior Resident
  • 2005.10
    -
    2007.08
    Tokyo Medical and Dental University, Medical Hospital, Hospital Departments, Departments of Surgery, Urology, Assistant Professor
  • 2011.01
    -
    2014.11
    Tokyo Medical and Dental University, Graduate School of Medical and Dental Sciences, Medical and Dental Sciences, Systemic Organ Regulation, Urology, Assistant Professor
  • 2014.12
    -
    2019.10
    Tokyo Medical and Dental University, Medical Hospital, Hospital Departments, Departments of Surgery, Urology, Junior Associate Professor
  • 2019.11
    -
    2020.03
    Tokyo Medical and Dental University, Medical Hospital, Hospital Departments, Departments of Surgery, Urology, Junior Associate Professor
  • 2020.04
    -
    2022.03
    Tokyo Medical and Dental University, Graduate School of Medical and Dental Sciences, Medical and Dental Sciences, Systemic Organ Regulation, Urology, Associate Professor
  • 2022.04
    -
    Now
    Tokyo Medical and Dental University, Graduate School of Medical and Dental Sciences, Medical and Dental Sciences, -, -, Visiting Lecturer

▼display all

External Career 【 display / non-display

  • 1998.05
    -
    1999.03
    , Trainee Resident

Academic Society Affiliations 【 display / non-display

  • Japanese Urological Association

  • Japanese Society of Minimum Incision Endoscopic Urological Surgery

  • European Association of Urology

  • Japan Society of Urologic Oncology

  • Japanese Society of Endourology

Academic Activity 【 display / non-display

  • 2018.07
    -
    Now
    International Symposium on Focal Therapy and Imaging in Prostate and Kidney Cancer Faculty member

Research Areas 【 display / non-display

  • Urology

Qualification Acquired 【 display / non-display

  • Doctor

 

Published Papers & Misc 【 display / non-display

  1. Yasuda Y, Saito K, Tanaka H, Uehara S, Kijima T, Yoshida S, Yokoyama M, Matsuoka Y, Kihara K, Fujii Y. . Outcomes of gasless laparoendoscopic single-port partial nephrectomy in 356 consecutive patients: Feasibility of a clampless and sutureless technique Int J Urol. 2020.12;

  2. Yokoyama M, Masuda H, Ito M, Waseda Y, Moriyama S, Toide M, Uchida Y, Uehara S, Kijima T, Yoshida S, Ishioka J, Matsuoka Y, Saito K, Fujii Y. Longitudinal changes in patient-reported outcomes after artificial urinary sphincter implantation Low Urin Tract Symptoms. 2020.12;

  3. Yoshida S, Takahara T, Yokoyama M, Matsuoka Y, Yoshimura R, Fujii Y. . Can progressive site-directed therapy prolong the efficacy of subsequent androgen receptor axis-targeted drugs in oligometastatic castration-resistant prostate cancer? Int J Urol. 2020 Nov 2. doi: 10.1111/iju.14421.. 2020.11;

  4. Kijima T, Yamamoto H, Saito K, Kusuhara S, Yoshida S, Yokoyama M, Matsuoka Y, Numao N, Sakai Y, Matsubara N, Yuasa T, Masuda H, Yonese J, Kageyama Y, Fujii Y. Early C-reactive protein kinetics predict survival of patients with advanced urothelial cancer treated with pembrolizumab Cancer Immunol Immunother. 2020.09;

  5. Suto EG, Mabuchi Y, Toyota S, Taguchi M, Naraoka Y, Itakura N, Matsuoka Y, Fujii Y, Miyasaka N, Akazawa C. Advantage of fat-derived CD73 positive cells from multiple human tissues, prospective isolated mesenchymal stromal cells Sci Rep. 2020.09;

  6. Shunya Matsumoto, Toshiki Kijima, Yoh Matsuoka, Masahide Yamamoto, Yasuhisa Fujii. A case of recurrent thrombocytopenia involving divergent immune-related mechanisms associated with pembrolizumab. Eur J Cancer 131(2020) 104-107. doi: 10.1016/j.ejca.2020.02.043. 2020.05;

  7. Waseda Y, Kobayashi S, Kanda E, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Fujii Y. Impact of Bladder Neck Involvement on Recurrence in Patients With Non-muscle-invasive Bladder Cancer: An Analysis Based on a Time-dependent Model Clin Genitourin Cancer. 2020.04;

  8. Kijima T, Ito M, Ishioka J, Matsuoka Y, Saito K, Fujii Y. Treatment-induced changes in levels of brain natriuretic peptide in prostate cancer patients receiving gonadotropin-releasing hormone antagonists or agonists Int J Urol. 2020.04;

  9. Nakamura Y, Yokoyama M, Yoshida S, Tanaka H, Kijima T, Ishioka J, Matsuoka Y, Saito K, Minami I, Yoshimoto T, Naito S, Ogawa Y, Yamada T, Uchida S, Fujii Y. Postoperative renal impairment and longitudinal change in renal function after adrenalectomy in patients with Cushing's syndrome Int J Urol. 2020 Mar 11. doi: 10.1111/iju.14205. 2020.03;

  10. Yoshida S, Taniguchi N, Moriyama S, Matsuoka Y, Saito K, Fujii Y. . Application of virtual reality in patient explanation of magnetic resonance imaging-ultrasound fusion prostate biopsy. Int J Urol. 2020; 27: 471-472. doi: 10.1111/iju.14204.. 2020;

  11. Tanaka H, Fukushima H, Kijima T, Nakamura Y, Yajima S, Uehara S, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Kihara K, Fujii Y. Feasibility and outcomes of selective tetramodal bladder-preservation therapy in elderly patients with muscle-invasive bladder cancer Int J Urol. 2020; 27: 236-243. *Equal contribution. 2020;

  12. Kaneko K, Yoshida S, Yamamoto K, Arita Y, Kijima T, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Fujii Y. . Renal epithelioid angiomyolipoma: Incidence in a Japanese cohort and diagnostic utility of diffusion-weighted magnetic resonance imaging. Int J Urol. 2020 Jul;27(7):599-604. doi: 10.1111/iju.14251.. 2020;

  13. Fukushima H, Moriyama S, Waseda Y, Fukuda S, Uehara S, Tanaka H, Kijima T, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Fujii Y. Significance of Bladder Neck Involvement in Risk Substratification of Intermediate-Risk Non-muscle-invasive Bladder Cancer Eur Urol Focus. 2020;

  14. Fukushima H, Inoue M, Kijima T, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Fujii Y. Incidence and risk factors of hypertension following partial nephrectomy in patients with renal tumors: a cross-sectional study of postoperative home blood pressure and antihypertensive medications Clin Genitourin Cancer. 2020;

  15. Fukushima H, Kijima T, Fukuda S, Moriyama S, Uehara S, Yasuda Y, Tanaka H, Yoshida S, Yokoyama M, Matsuoka Y, Saito K, Matsubara N, Numao N, Sakai Y, Yuasa T, Masuda H, Yonese J, Kageyama Y, Fujii Y. Impact of radiotherapy to the primary tumor on the efficacy of pembrolizumab for patients with advanced urothelial cancer: a preliminary study Cancer Med. 2020; 9: 8355-8363. doi: 10.1002/cam4.3445. 2020;

  16. Fukushima H, Fukuda S, Moriyama S, Uehara S, Yasuda Y, Tanaka H, Yoshida S, Yokoyama M, Matsuoka Y, Fujii Y. Impact of sarcopenia on the efficacy of pembrolizumab in patients with advanced urothelial carcinoma: a preliminary report Anticancer Drugs. 2020; 31: 866-871. doi: 10.1097/CAD.0000000000000982.. 2020;

  17. Matsuoka Y, Uehara S, Yoshida S, Tanaka H, Yokoyama M, Fujii Y. Three-dimensional analysis of systematic biopsy-derived prostate cancer upgrading over targeted biopsy Int J Urol. 2020 Oct 27. doi: 10.1111/iju.14410. 2020;

  18. Matsuoka Y, Uehara S, Yoshida S, Tanaka H, Tanaka H, Kijima T, Yokoyama M, Ishioka J, Saito K, Fujii Y. Value of extra-target prostate biopsy for the detection of magnetic resonance imaging-missed adverse pathology according to the Prostate Imaging Reporting and Data System scores Spatial analysis using magnetic resonance-ultrasound fusion images. Int J Urol. 2020; 27: 760-766. 2020;

  19. SoichiroYoshida1TaroTakahara23ChikakoIshii3YukiArita34YumaWaseda1ToshikiKijima1MinatoYokoyama1JunichiroIshioka1YohMatsuoka1KazutakaSaito1YasuhisaFujii. METastasis Reporting and Data System for Prostate Cancer as a Prognostic Imaging Marker in Castration-resistant Prostate Cancer 2019.12;

  20. Takahiko Soma, Junichiro Ishioka, Hajime Tanaka, Yoh Matsuoka, Kazutaka Saito, Yasuhisa Fujii. Potential for computer-aided diagnosis using a convolutional neural network algorithm to diagnose fat-poor angiomyolipoma in enhanced computed tomography and T2-weighted magnetic resonance imaging. Int. J. Urol.. 2018.08; 25 (11): 978-979. ( PubMed, DOI )

  21. Hajime Tanaka, Soichiro Yoshida, Fumitaka Koga, Kazuma Toda, Ryoichi Yoshimura, Yutaka Nakajima, Emiko Sugawara, Takumi Akashi, Yuma Waseda, Masaharu Inoue, Toshiki Kijima, Minato Yokoyama, Junichiro Ishioka, Yoh Matsuoka, Kazutaka Saito, Kazunori Kihara, Yasuhisa Fujii. Impact of Immunohistochemistry-Based Subtypes in Muscle-Invasive Bladder Cancer on Response to Chemoradiotherapy. Int. J. Radiat. Oncol. Biol. Phys.. 2018.06; ( PubMed, DOI )

  22. Junichiro Ishioka, Yoh Matsuoka, Sho Uehara, Yosuke Yasuda, Toshiki Kijima, Soichiro Yoshida, Minato Yokoyama, Kazutaka Saito, Kazunori Kihara, Noboru Numao, Tomo Kimura, Kosei Kudo, Itsuo Kumazawa, Yasuhisa Fujii. Computer-aided diagnosis of prostate cancer on magnetic resonance imaging using a convolutional neural network algorithm. BJU Int.. 2018.05; 122 (3): 411-417. ( PubMed, DOI )

  23. Toshiki Kijima, Thomas Prince, Katsuo Mori, Soichiro Yoshida, Minato Yokoyama, Junichiro Ishioka, Yoh Matsuoka, Kazutaka Saito, and others. TARGETING HEAT SHOCK FACTOR 1 SENSITIZES CASTRATION-RESISTANT PROSTATE CANCER CELLS TO HSP90 INHIBITION IN PART BY DESTABILIZING ANDROGEN RECEPTOR SPLICE VARIANTS the journal of UROLOGY. 2018.04;

  24. Yosuke Yasuda, Kazutaka Saito, Takahiko Soma, Toshiki Kijima, Soichiro Yoshida, Minato Yokoyama, Junichiro Ishioka, Yoh Matsuoka, and others. THE OUTCOME OF GASLESS LAPAROSCOPIC SINGLE-PORT CLAMPLESS SUTURELESS PARTIAL NEPHRECTOMY USING THREE-DIMENSIONAL HEAD-MOUNTED DISPLAY the journal of UROLOGY. 2018.04;

  25. shugo yajima, Soichiro Yoshida、 Taro Takahara Minato Junichiro Ishioka, Yoh Matsuoka, Kazutaka Saito, Kazunori Kihara, Yasuhisa Fujii . ABSENCE OF INCHWORM SIGN ON DWI: A PREDICTIVE MARKER FOR PROGRESSION IN PT1 BLADDER CANCER the journal of UROLOGY. 2018.04;

  26. Yoh Matsuoka, Junichiro Ishioka, Hiroshi Tanaka, Tomo Kimura, Yuma Waseda, Sho Uehara, Yosuke Yasuda, Toshiki Kijima, and others. MRI-BASED RISK ASSESSMENT FOR POSTOPERATIVE BIOCHEMICAL RECURRENCE USING THE PROSTATE IMAGING REPORTING AND DATA SYSTEM (PI-RADS) SCORES AND CAPSULAR CONTACT LENGTH the journal of UROLOGY. 2018.04;

  27. Minato Yokoyama, Naoko Kawamura, Sho Uehara, Yosuke Yasuda, Toshiki Kijima, Soichiro Yoshida, Junichiro Ishioka, Yoh Matsuoka, and others. ACUTE KIDNEY INJURY AND INTERMEDIATE-TERM RENAL FUNCTION AFTER CLAMPLESS PARTIAL NEPHRECTOMY the journal of UROLOGY. 2018.04;

  28. Junichiro Ishioka, Yoh Matsuoka, Sho Uehara, Yosuke Yasuda, Toshiki Kijima, Soichiro Yoshida, Minato Yokoyama, Kazutaka Saito, and others. DEEP LEARNING WITH A CONVOLUTIONAL NEURAL NETWORK ALGORITHM FOR FULLY AUTOMATED DETECTION OF PROSTATE CANCER USING PRE-BIOPSY MRI the journal of UROLOGY. 2018.04;

  29. Yoh Matsuoka, Hiroshi Tanaka, Tomo Kimura, Yuma Waseda, Sho Uehara, Yosuke Yasuda, Toshiki Kijima, Soichiro Yoshida, and others. THE ROLE OF MRI-TARGETED BIOPSY IN PREDICTION OF ADVERSE PATHOLOGICAL AND ONCOLOGICAL OUTCOME AFTER RADICAL PROSTATECTOMY the journal of UROLOGY. 2018.04;

  30. Shingo Moriyama, Soichiro Yoshida, Hajime Tanaka, Hiroshi Tanaka, Minato Yokoyama, Junichiro Ishioka, Yoh Matsuoka, Kazutaka Saito, Kazunori Kihara, Yasuhisa Fujii. Intensity ratio curve analysis of small renal masses on T2-weighted magnetic resonance imaging: Differentiation of fat-poor angiomyolipoma from renal cell carcinoma. Int. J. Urol.. 2018.03; 25 (6): 554-560. ( PubMed, DOI )

  31. Sho Uehara, Soichiro Yoshida, Hiroshi Tanaka, Yosuke Yasuda, Hajime Tanaka, Toshiki Kijima, Minato Yokoyama, Junichiro Ishioka, Yoh Matsuoka, Kazutaka Saito, Yasuhisa Fujii. Prediction of Intraoperative Urinary Collecting System Entry in Patients with Peripheral Renal Tumors Undergoing Partial Nephrectomy: Usefulness of Tumor-Centered Multiplanar Reconstruction. Urol. Int.. 2018.01; 100 (1): 85-91. ( PubMed, DOI )

  32. Yosuke Yasuda, Kazutaka Saito, Takeshi Yuasa, Sho Uehara, Naoko Kawamura, Minato Yokoyama, Junichiro Ishioka, Yoh Matsuoka, Shinya Yamamoto, Tetsuo Okuno, Junji Yonese, Kazunori Kihara, Yasuhisa Fujii. Early response of C-reactive protein as a predictor of survival in patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitors. Int. J. Clin. Oncol.. 2017.12; 22 (6): 1081-1086. ( PubMed, DOI )

  33. Yuma Waseda, Soichiro Yoshida, Taro Takahara, Thomas Christian Kwee, Yoh Matsuoka, Kazutaka Saito, Kazunori Kihara, Yasuhisa Fujii. Utility of computed diffusion-weighted MRI for predicting aggressiveness of prostate cancer. J Magn Reson Imaging. 2017.08; 46 (2): 490-496. ( PubMed, DOI )

  34. Yoh Matsuoka, Junichiro Ishioka, Hiroshi Tanaka, Tomo Kimura, Soichiro Yoshida, Kazutaka Saito, Yasuhisa Fujii, Kazunori Kihara. Impact of the Prostate Imaging Reporting and Data System, Version 2, on MRI Diagnosis for Extracapsular Extension of Prostate Cancer. AJR Am J Roentgenol. 2017.08; 209 (2): W76-W84. ( PubMed, DOI )

  35. Toshinori Nishizawa, Soichiro Yoshida, Fumitaka Koga, Hiroshi Tanaka, Mihiro Kaga, Kotaro Watanabe, Hiroshi Fukushima, Yasukazu Nakanishi, Minato Yokoyama, Junichiro Ishioka, Yoh Matsuoka, Kazutaka Saito, Yasuhisa Fujii, Kazunori Kihara. Standardization of the apparent diffusion coefficient value of bladder cancer across different centers: Applicability in predicting aggressive pathologic phenotypes. Clin Imaging. 2017.07; 44 121-126. ( PubMed, DOI )

  36. Hajime Tanaka, Yasuhisa Fujii, Hiroshi Tanaka, Junichiro Ishioka, Yoh Matsuoka, Kazutaka Saito, Sho Uehara, Noboru Numao, Takeshi Yuasa, Shinya Yamamoto, Hitoshi Masuda, Junji Yonese, Kazunori Kihara. Stepwise algorithm using computed tomography and magnetic resonance imaging for diagnosis of fat-poor angiomyolipoma in small renal masses: Development and external validation. Int. J. Urol.. 2017.07; 24 (7): 511-517. ( PubMed, DOI )

  37. Hajime Tanaka, Yasuhisa Fujii, Junichiro Ishioka, Yoh Matsuoka, Kazutaka Saito, Kazunori Kihara. Absence of renal artery pseudoaneurysm on computed tomography after minimally-invasive partial nephrectomy using clampless and sutureless techniques. Int. J. Urol.. 2017.06; 24 (6): 472-473. ( PubMed, DOI )

  38. Yuki Nakamura, Soichiro Yoshida, Hiroshi Tanaka, Masaharu Inoue, Masaya Ito, Toshiki Kijima, Minato Yokoyama, Junichiro Ishioka, Yoh Matsuoka, Kazutaka Saito, Yasuhisa Fujii, Kazunori Kihara. Potential Utility of Diffusion-Weighted Magnetic Resonance Imaging in Diagnosis of Residual Bladder Cancer before Second Transurethral Resection. Urol. Int.. 2017.03; 98 (3): 298-303. ( PubMed, DOI )

  39. Naoko Kawamura, Minato Yokoyama, Yasuhisa Fujii, Junichiro Ishioka, Noboru Numao, Yoh Matsuoka, Kazutaka Saito, Chizuru Arisawa, Tetsuo Okuno, Akira Noro, Shinji Morimoto, Kazunori Kihara. Recovery of renal function after radical nephrectomy and risk factors for postoperative severe renal impairment: A Japanese multicenter longitudinal study. Int. J. Urol.. 2016.03; 23 (3): 219-223. ( PubMed, DOI )

  40. Takayuki Nakayama, Noboru Numao, Soichiro Yoshida, Junichiro Ishioka, Yoh Matsuoka, Kazutaka Saito, Yasuhisa Fujii, Kazunori Kihara. A novel interactive educational system in the operating room--the IE system. BMC Med Educ. 2016.02; 16 44. ( PubMed, DOI )

  41. Matsuoka Yoh, Numao Noboru, Saito Kazutaka, Tanaka Hiroshi, Kumagai Jiro, Yoshida Soichiro, Ishioka Junichiro, Koga Fumitaka, Masuda Hitoshi, Kawakami Satoru, Fujii Yasuhisa, Kihara Kazunori. Candidate selection for quadrant-based focal ablation through a combination of diffusion-weighted magnetic resonance imaging and prostate biopsy. BJU Int. 2016.01; 117 (1): 94-101. ( PubMed, DOI )

  42. Kazunori Kihara, Fumitaka Koga, Yasuhisa Fujii, Hitoshi Masuda, Manabu Tatokoro, Minato Yokoyama, Yoh Matsuoka, Noboru Numao, Junichiro Ishioka, Kazutaka Saito. Gasless laparoendoscopic single-port clampless sutureless partial nephrectomy for peripheral renal tumors: perioperative outcomes. Int. J. Urol.. 2015.04; 22 (4): 349-355. ( PubMed, DOI )

  43. Soichiro Yoshida, Masaya Ito, Manabu Tatokoro, Minato Yokoyama, Junichiro Ishioka, Yoh Matsuoka, Noboru Numao, Kazutaka Saito, Yasuhisa Fujii, Kazunori Kihara. Multitask Imaging Monitor for Surgical Navigation: Combination of Touchless Interface and Head-Mounted Display. Urol. Int.. 2015.04; ( PubMed, DOI )

  44. Masaya Ito, Kazunori Kihara, Soichiro Yoshida, Manabu Tatokoro, Minato Yokoyama, Junichiro Ishioka, Yoh Matsuoka, Noboru Numao, Kazutaka Saito, Yasuhisa Fujii. Patient's Self-monitoring of Transurethral Surgical Images Using a Head-mounted Display Urology Case Reports. 2015.03; 3 (2): 27-29. ( DOI )

  45. Inoue Masaharu, Kihara Kazunori, Yoshida Soichiro, Ito Masaya, Takeshita Hideki, Ishioka Junichiro, Matsuoka Yoh, Numao Noboru, Saito Kazutaka, Fujii Yasuhisa. A novel approach to patient self-monitoring of sonographic examinations using a head-mounted display. J Ultrasound Med. 2015.01; 34 (1): 29-35. ( PubMed, DOI )

  46. Matsuoka Yoh, Kihara Kazunori, Kawashima Kenji, Fujii Yasuhisa. Integrated image navigation system using head-mounted display in "RoboSurgeon" endoscopic radical prostatectomy. Wideochir Inne Tech Malo Inwazyjne. 2014.12; 9 (4): 613-618. ( PubMed, DOI )

  47. Fujii Yasuhisa, Kihara Kazunori, Yoshida Soichiro, Ishioka Junichiro, Matsuoka Yoh, Numao Noboru, Saito Kazutaka. A three-dimensional head-mounted display system (RoboSurgeon system) for gasless laparoendoscopic single-port partial cystectomy. Wideochir Inne Tech Malo Inwazyjne. 2014.12; 9 (4): 638-643. ( PubMed, DOI )

  48. Fukushima Hiroshi, Saito Kazutaka, Ishioka Junichiro, Matsuoka Yoh, Numao Noboru, Koga Fumitaka, Masuda Hitoshi, Fujii Yasuhisa, Sakai Yasuyuki, Arisawa Chizuru, Okuno Tetsuo, Yonese Junji, Kamata Shigeyoshi, Nagahama Katsushi, Noro Akira, Morimoto Shinji, Tsujii Toshihiko, Kitahara Satoshi, Gotoh Shuichi, Higashi Yotsuo, Kihara Kazunori. Equivalent survival and improved preservation of renal function after distal ureterectomy compared with nephroureterectomy in patients with urothelial carcinoma of the distal ureter: a propensity score-matched multicenter study. Int J Urol. 2014.11; 21 (11): 1098-1104. ( PubMed, DOI )

  49. Ishioka J, Masuda H, Kijima T, Tatokoro M, Yoshida S, Yokoyama M, Matsuoka Y, Numao N, Koga F, Saito K, Fujii Y, Sakai Y, Arisawa C, Okuno T, Nagahama K, Kamata S, Yonese J, Kageyama Y, Noro A, Morimoto S, Tsujii T, Kitahara S, Gotoh S, Kihara K. Bimodal pattern of the impact of body mass index on cancer-specific survival of upper urinary tract urothelial carcinoma patients. Anticancer Res. 2014.10; 34 (10): 5683-5688.

  50. Uchida Y, Yoshida S, Kobayashi S, Koga F, Ishioka J, Satoh S, Ishii C, Tanaka H, Matsuoka Y, Numao N, Saito K, Masuda H, Fujii Y, Kihara K. Diffusion-weighted MRI as a potential imaging biomarker reflecting the metastatic potential of upper urinary tract cancer. Br J Radiol. 2014.10; 87 (1042): 20130791. ( PubMed, DOI )

  51. Takeshita Hideki, Kihara Kazunori, Yoshida Soichiro, Higuchi Saori, Ito Masaya, Nakanishi Yasukazu, Kijima Toshiki, Ishioka Junichiro, Matsuoka Yoh, Numao Noboru, Saito Kazutaka, Fujii Yasuhisa. Clinical application of a modern high-definition head-mounted display in sonography. J Ultrasound Med. 2014.08; 33 (8): 1499-1504. ( PubMed, DOI )

  52. Yoshida Soichiro, Kihara Kazunori, Takeshita Hideki, Nakanishi Yasukazu, Kijima Toshiki, Ishioka Junichiro, Matsuoka Yoh, Numao Noboru, Saito Kazutaka, Fujii Yasuhisa. Head-Mounted Display for a Personal Integrated Image Monitoring System: Ureteral Stent Placement. Urol Int. 2014.08; ( PubMed, DOI )

  53. Nakayama Takayuki, Saito Kazutaka, Fujii Yasuhisa, Abe-Suzuki Shiho, Nakanishi Yasukazu, Kijima Toshiki, Yoshida Soichiro, Ishioka Junichiro, Matsuoka Yoh, Numao Noboru, Koga Fumitaka, Kihara Kazunori. Pre-operative risk stratification for cancer-specific survival in patients with renal cell carcinoma with venous involvement who underwent nephrectomy. Jpn J Clin Oncol. 2014.08; 44 (8): 756-761. ( PubMed, DOI )

  54. Koga Fumitaka, Kobayashi Shuichiro, Fujii Yasuhisa, Ishioka Junichiro, Yokoyama Minato, Nakanishi Yasukazu, Matsuoka Yoh, Numao Noboru, Saito Kazutaka, Masuda Hitoshi, Kihara Kazunori. Significance of positive urine cytology on progression and cancer-specific mortality of non--muscle-invasive bladder cancer. Clin Genitourin Cancer. 2014.06; 12 (3): e87-e93. ( PubMed, DOI )

  55. Matsuoka Yoh. Editorial Comment to Soft coagulation in partial nephrectomy without renorrhaphy: feasibility of a new technique and early outcomes. Int J Urol. 2014.03; 21 (3): 248. ( PubMed, DOI )

  56. Bae Hyeyeol, Yoshida Soichiro, Matsuoka Yoh, Nakajima Hiroshi, Ito Eisaku, Tanaka Hiroshi, Oya Miyako, Nakayama Takayuki, Takeshita Hideki, Kijima Toshiki, Ishioka Junichiro, Numao Noboru, Koga Fumitaka, Saito Kazutaka, Akashi Takumi, Fujii Yasuhisa, Kihara Kazunori. Apparent diffusion coefficient value as a biomarker reflecting morphological and biological features of prostate cancer. Int Urol Nephrol. 2014.03; 46 (3): 555-561. ( PubMed, DOI )

  57. Nakayama T, Saito K, Ishioka J, Kawano K, Morimoto S, Matsuoka Y, Okuno T, Moriyama S, Takeshita H, Noro A, Fujii Y, Kihara K. External validation of TNM-C score in three community hospital cohorts for clear cell renal cell carcinoma. Anticancer Res. 2014.02; 34 (2): 921-926.

  58. Ishioka Junichiro, Saito Kazutaka, Kijima Toshiki, Nakanishi Yasukazu, Yoshida Soichiro, Yokoyama Minato, Matsuoka Yoh, Numao Noboru, Koga Fumitaka, Masuda Hitoshi, Fujii Yasuhisa, Sakai Yasuyuki, Arisawa Chizuru, Okuno Tetsuo, Nagahama Katsuhi, Kamata Shigeyoshi, Sakura Mizuaki, Yonese Junji, Morimoto Shinji, Noro Akira, Tsujii Toshihiko, Kitahara Satoshi, Gotoh Shuichi, Higashi Yotsuo, Kihara Kazunori. Risk stratification for bladder recurrence of upper urinary tract urothelial carcinoma after radical nephroureterectomy. BJU Int. 2014.02; ( PubMed, DOI )

  59. Matsuoka Yoh, Numao Noboru, Saito Kazutaka, Tanaka Hiroshi, Kumagai Jiro, Yoshida Soichiro, Koga Fumitaka, Masuda Hitoshi, Kawakami Satoru, Fujii Yasuhisa, Kihara Kazunori. Combination of diffusion-weighted magnetic resonance imaging and extended prostate biopsy predicts lobes without significant cancer: application in patient selection for hemiablative focal therapy. Eur Urol. 2014.01; 65 (1): 186-192. ( PubMed, DOI )

  60. Kobayashi Shuichiro, Fujii Yasuhisa, Koga Fumitaka, Yokoyama Minato, Ishioka Junichiro, Matsuoka Yoh, Numao Noboru, Saito Kazutaka, Masuda Hitoshi, Kihara Kazunori. Impact of bladder neck involvement on progression in patients with primary non-muscle invasive bladder cancer: a prospective validation study. Urol Oncol. 2014.01; 32 (1): 38.e29-38.e36. ( PubMed, DOI )

  61. Ishioka J, Kihara K, Higuchi S, Nakayama T, Takeshita H, Yoshida S, Nakanishi Y, Kijima T, Matsuoka Y, Numao N, Saito K, Fujii Y.. New head-mounted display system applied to endoscopic management of upper urinary tract carcinomas. Int Braz J Urol. 2014; 40 (6): 842-845. ( DOI )

  62. Yachida Yuki, Yoshida Soichiro, Takeshita Hideki, Sawamura Chigusa, Tanaka Hiroshi, Satoh Shiro, Uchida Yusuke, Ishioka Junichiro, Matsuoka Yoh, Numao Noboru, Koga Fumitaka, Saito Kazutaka, Fujii Yasuhisa, Kihara Kazunori. Bone abnormal signal incidentally found in pre-biopsy diffusion-weighted MRI for suspected prostate cancer: what does it reflect? Urol Int. 2014; 93 (2): 170-175. ( PubMed, DOI )

  63. Komai Yoshinobu, Numao Noboru, Yoshida Soichiro, Matsuoka Yoh, Nakanishi Yasukazu, Ishii Chikako, Koga Fumitaka, Saito Kazutaka, Masuda Hitoshi, Fujii Yasuhisa, Kawakami Satoru, Kihara Kazunori. High diagnostic ability of multiparametric magnetic resonance imaging to detect anterior prostate cancer missed by transrectal 12-core biopsy. J Urol. 2013.09; 190 (3): 867-873. ( PubMed, DOI )

  64. Yoshida Soichiro, Kobayashi Shuichiro, Koga Fumitaka, Ishioka Junichiro, Ishii Chikako, Tanaka Hiroshi, Nakanishi Yasukazu, Matsuoka Yoh, Numao Noboru, Saito Kazutaka, Masuda Hitoshi, Fujii Yasuhisa, Kihara Kazunori. Apparent diffusion coefficient as a prognostic biomarker of upper urinary tract cancer: a preliminary report. Eur Radiol. 2013.08; 23 (8): 2206-2214. ( PubMed, DOI )

  65. Numao Noboru, Yoshida Soichiro, Komai Yoshinobu, Ishii Chikako, Kagawa Makoto, Kijima Toshiki, Yokoyama Minato, Ishioka Junichiro, Matsuoka Yoh, Koga Fumitaka, Saito Kazutaka, Masuda Hitoshi, Fujii Yasuhisa, Kawakami Satoru, Kihara Kazunori. Usefulness of pre-biopsy multiparametric magnetic resonance imaging and clinical variables to reduce initial prostate biopsy in men with suspected clinically localized prostate cancer. J Urol. 2013.08; 190 (2): 502-508. ( PubMed, DOI )

  66. Fukushima Hiroshi, Masuda Hitoshi, Yokoyama Minato, Tatokoro Manabu, Yoshida Soichiro, Ishioka Junichiro, Matsuoka Yoh, Numao Noboru, Koga Fumitaka, Saito Kazutaka, Fujii Yasuhisa, Kihara Kazunori. Diabetes mellitus with obesity is a predictor of recurrence in patients with non-metastatic renal cell carcinoma. Jpn J Clin Oncol. 2013.07; 43 (7): 740-746. ( PubMed, DOI )

  67. Masuda Hitoshi, Kagawa Makoto, Kawakami Satoru, Numao Noboru, Matsuoka Yoh, Yokoyama Minato, Yamamoto Shinya, Yonese Junji, Fukui Iwao, Kihara Kazunori. Body mass index influences prostate cancer risk at biopsy in Japanese men. Int J Urol. 2013.07; 20 (7): 701-707. ( PubMed, DOI )

  68. Takeshita Hideki, Numao Noboru, Kijima Toshiki, Yokoyama Minato, Ishioka Junichiro, Matsuoka Yoh, Koga Fumitaka, Saito Kazutaka, Masuda Hitoshi, Kawakami Satoru, Yamamoto Shinya, Yonese Junji, Fujii Yasuhisa, Kihara Kazunori. Diagnostic performance of initial transperineal 14-core prostate biopsy to detect significant cancer. Int Urol Nephrol. 2013.06; 45 (3): 645-652. ( PubMed, DOI )

  69. Kijima Toshiki, Fujii Yasuhisa, Yokoyama Minato, Ishioka Junichiro, Matsuoka Yoh, Numao Noboru, Saito Kazutaka, Koga Fumitaka, Masuda Hitoshi, Kawakami Satoru, Kihara Kazunori. Prostate-specific antigen response to deferred combined androgen blockade therapy using bicalutamide predicts survival after subsequent oestrogen and docetaxel therapies in patients with castration-resistant prostate cancer. BJU Int. 2012.10; 110 (8): 1149-1155. ( PubMed, DOI )

  70. Kihara Kazunori, Fujii Yasuhisa, Masuda Hitoshi, Saito Kazutaka, Koga Fumitaka, Matsuoka Yoh, Numao Noboru, Kojima Kazuyuki. New three-dimensional head-mounted display system, TMDU-S-3D system, for minimally invasive surgery application: procedures for gasless single-port radical nephrectomy. Int J Urol. 2012.09; 19 (9): 886-889. ( PubMed, DOI )

  71. Ishioka J, Saito K, Sakura M, Yokoyama M, Matsuoka Y, Numao N, Koga F, Masuda H, Fujii Y, Kawakami S, Kihara K. Development of a nomogram incorporating serum C-reactive protein level to predict overall survival of patients with advanced urothelial carcinoma and its evaluation by decision curve analysis. Br J Cancer. 2012.09; 107 (7): 1031-1036. ( PubMed, DOI )

  72. Tatokoro Manabu, Fujii Yasuhisa, Kawakami Satoru, Saito Kazutaka, Koga Fumitaka, Matsuoka Yoh, Iimura Yasumasa, Masuda Hitoshi, Kihara Kazunori. Phase-II trial of combination treatment of interferon-alpha, cimetidine, cyclooxygenase-2 inhibitor and renin-angiotensin-system inhibitor (I-CCA therapy) for advanced renal cell carcinoma. Cancer Sci. 2011.01; 102 (1): 137-143. ( PubMed, DOI )

  73. Masuda Hitoshi, Kawano Keizo, Matsuoka Yoh, Yokoyama Minato, Koga Fumitaka, Saito Kazutaka, Kihara Kazunori, Azuma Hiroshi. Interactions between inducible nitric oxide synthase and cyclooxygenase-2 in response to ischaemia-reperfusion of rabbit bladder. BJU Int. 2010.09; 106 (5): 716-722. ( PubMed, DOI )

  74. Sakai Yasuyuki, Okuno Tetsuo, Kijima Toshiki, Iwai Aki, Matsuoka Yoh, Kawakami Satoru, Kihara Kazunori. Simple prophylactic procedure of inguinal hernia after radical retropubic prostatectomy: isolation of the spermatic cord. Int J Urol. 2009.10; 16 (10): 848-851. ( PubMed, DOI )

  75. Sakura Mizuaki, Masuda Hitoshi, Matsuoka Yoh, Yokoyama Minato, Kawakami Satoru, Kihara Kazunori. Rolipram, a specific type-4 phosphodiesterase inhibitor, inhibits cyclophosphamide-induced haemorrhagic cystitis in rats. BJU Int. 2009.01; 103 (2): 264-269. ( PubMed, DOI )

  76. Matsuoka Yoh, Arai Gaku, Okada Yume, Aida Junko. Prostate cancer-producing granulocyte colony-stimulating factor. Urol Int. 2009; 82 (1): 113-115. ( PubMed, DOI )

  77. Matsuoka Yoh, Hirokawa Makoto, Chiba Kimio, Hashiba Takafumi, Tomoda Takeshi, Sugiura Shimpei. Biphasic and monophasic sarcomatoid carcinoma of the urinary bladder. Can J Urol. 2008.06; 15 (3): 4106-4108. ( PubMed )

  78. Matsuoka Yoh, Kobayashi Tohru, Kihara Kazunori, Nagahama Yoshitaka. Molecular cloning of Plk1 and Nek2 and their expression in mature gonads of the teleost fish Nile tilapia (Oreochromis niloticus). Mol Reprod Dev. 2008.06; 75 (6): 989-1001. ( PubMed, DOI )

  79. Masuda Hitoshi, Kihara Kazunori, Saito Kazutaka, Matsuoka Yoh, Yoshida Soichiro, Chancellor Michael B, de Groat William C, Yoshimura Naoki. Reactive oxygen species mediate detrusor overactivity via sensitization of afferent pathway in the bladder of anaesthetized rats. BJU Int. 2008.03; 101 (6): 775-780. ( PubMed, DOI )

  80. Matsuoka Yoh, Masuda Hitoshi, Yokoyama Minato, Kihara Kazunori. Protective effects of bilirubin against cyclophosphamide induced hemorrhagic cystitis in rats. J Urol. 2008.03; 179 (3): 1160-1166. ( PubMed, DOI )

  81. Matsuoka Yoh, Arai Gaku, Ishimaru Hisashi, Takagi Kentaro, Ito Yuji. Primary signet-ring cell carcinoma of the prostate. Can J Urol. 2007.12; 14 (6): 3764-3766. ( PubMed )

  82. Matsuoka Yoh, Masuda Hitoshi, Yokoyama Minato, Kihara Kazunori. Protective effects of heme oxygenase-1 against cyclophosphamide-induced haemorrhagic cystitis in rats. BJU Int. 2007.12; 100 (6): 1402-1408. ( PubMed, DOI )

  83. Matsuoka Yoh, Arai Gaku, Ishimaru Hisashi, Takagi Kentaro, Aida Junko, Okada Yume. Xanthogranulomatous pyelonephritis with a renocolic fistula caused by a parapelvic cyst. Int J Urol. 2006.04; 13 (4): 433-435. ( PubMed, DOI )

  84. Matsuoka Y, Machida T, Oka K, Ishizaka K. Clear cell adenocarcinoma of the urinary bladder inducing acute renal failure. Int J Urol. 2002.08; 9 (8): 467-469.

  85. Matsuoka Y, Fujii Y, Akashi T, Gosehi N, Kihara K. Primitive neuroectodermal tumour of the adrenal gland. BJU Int. 1999.03; 83 (4): 515-516. ( PubMed )

▼display all

Books etc 【 display / non-display

  1. Kazunori Kihara, Yasuhisa Fujii, Kazutaka Saito, Fumitaka Koga, Noboru Numao, Yoh Matsuoka, Junichiro Ishioka, Minato Yokoyama, Hitoshi Masuda, Tatsuya Nagai, Soichiro Yoshida, Manabu Tatokoro, Toshiki Kijima, Naoko Kawamura, Masaharu Inoue, Masaya Ito. Gasless Single-Port RoboSurgeon Surgery in Urology. Springer, 2015.09 (ISBN : 978-4-431-54504-0)

Conference Activities & Talks 【 display / non-display

  1. 松岡 陽. 限局性前立腺癌の個別化治療戦略:Focal Therapyの現状と可能 性. 第18回Yushima Urological Seminar 2021.03.09

  2. 福島啓司、木島敏樹、吉田宗一郎、横山みなと、石岡淳一郎、松岡陽、斎藤一隆、松原伸晃、湯浅健、増田均、米瀬淳二、影山幸雄、藤井靖久. 進行尿路上皮癌症例におけるペムブロリズマブの治療効果及び予後:化学放射線療法の治療歴との関連. 第108回 日本泌尿器科学会総会 2020.12.24

  3. Matsuoka Y, Uehara S, Yoshida S, Tanaka H, Fukuda S, Fukushima H, Moriyama S, Tanaka H, Kijima T, Yokoyama M, Ishioka J, Saito K, Fujii Y. Who benefits from extra-target sampling in addition to intra-target sampling for the detection of adverse prostate pathology?: Stereological analysis of biopsy-proven cancer sites. The 35th Annual Congress of the European Association of Urology 2020.07.17 Amsterdam Netherlands.

  4. Matsuoka Y, Ishioka J, Tanaka H, Fukuda S, Fukushima H, Moriyama S, Uehara S, Tanaka H, Kijima T, Yoshida S, Yokoyama M, Saito K, Fujii Y. Apparent diffusion coefficient ratio as a quantitative imaging marker: Utility in a nomogram for predicting biochemical recurrence after radical prostatectomy. The 115th annual meeting of the American Urological Association 2020.05.15 Washington DC, USA

  5. Matsuoka Y, Uehara S, Yoshida S, Tanaka H, Fukuda S, Fukushima H, Moriyama S, Tanaka H, Kijima T, Yokoyama M, Ishioka J, Saito K, Fujii Y. Who needs extra-target sampling in addition to intra-target sampling for the detection of adverse prostate pathology?: Spatial analysis of biopsy-proven cancer sites. The 115th annual meeting of the American Urological Association 2020.05.15 Washington DC, USA

  6. Matsuoka Y, Uehara S, Yoshida S, Tanaka H, Fukuda S, Fukushima H, Moriyama S, Tanaka H, Kijima T, Yokoyama M, Ishioka J, Saito K, Fujii Y. Value of extra-target sampling in addition to intra-target sampling for the detection of prostate cancer upgrading according to PIRADS scores. 12th International Symposium on Focal Therapy and Imaging in Prostate & Kidney Cancer 2020.02.09 Washington DC, USA

  7. Matsumoto S, Yoshida S, Yamada I, Kijima T, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Tateishi U, Fujii Y. Utility of diffusion-weighted MRI radiomics features in differentiation of fat-poor angiomyolipoma from clear cell renal cell carcinoma.. The 35th Annual Congress of the European Association of Urology, 2020 2020 Amsterdam Netherlands.

  8. Rie Kato, Hiroshi Fukushima, Toshiki Kijima, Soichiro Yoshida, Minato Yokoyama, Ishioka Junichiro, Yoh Matsuoka, Kazutaka Saito, Yukihiro Otsuka, Fumitaka Koga, Masataka Yano, Tetsuro Tsukamoto, Hitoshi Masuda, Tetsuo Okuno, Junji Yonese, Katsushi Nagahama, Shigeyoshi Kamata, Akira Noro, Yukio Kageyama, Toshihiko Tsujii, Shinji Morimoto, Yasuhisa Fujii.. The qSOFA score outperforms the SIRS score in predicting in-hospital mortality of obstructive pyelonephritis patients: results from a multi-institutional study.. 114th annual meeting of the American Urological Association, 2020 2020 Washington DC, USA

  9. Rie Kato, Hiroshi Fukushima, Toshiki Kijima, Soichiro Yoshida, Minato Yokoyama, Ishioka Junichiro, Yoh Matsuoka, Kazutaka Saito, Yukihiro Otsuka, Fumitaka Koga, Masataka Yano, Tetsuro Tsukamoto, Hitoshi Masuda, Tetsuo Okuno, Junji Yonese, Katsushi Nagahama, Shigeyoshi Kamata, Akira Noro, Yukio Kageyama, Toshihiko Tsujii, Shinji Morimoto, Yasuhisa Fujii.. Predictive performance of the qSOFA score for in-hospital mortality of obstructive pyelonephritis patients: a multi-institutional study.. The 35th Annual Congress of the European Association of Urology, 2020 2020 Amsterdam Netherlands.

  10. Ito T, Yoshida S, Taniguchi N, Sugimoto M, Moriyama S, Uehara S, Tanaka H, Kijima T, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Fujii Y. The utility of mixed reality model projection in ultrasound training for medical students.. 114th annual meeting of the American Urological Association, 2020 2020 Washington DC, USA

  11. Yoshida S., Takahara T., Ishii C., Nakagawa K., Toda K., Arita Y., Kijima T., Yokoyama M., Ishioka J., Matsuoka Y., Saito K., Yoshimura R., Fujii Y. Treatment outcomes of progressive site-directed therapy for oligoprogressive castration-resistant prostate cancer. . The 35th Annual Congress of the European Association of Urology, 2020 2020 Amsterdam, Netherlands

  12. Yoshida S, Takahara T, Ishii C, Nakagawa K, Toda K, Arita Y, Kijima T, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Yoshimura R, Fujii Y. Treatment outcomes of progressive site-directed therapy for oligoprogressive castration-resistant prostate cancer. . 114th annual meeting of the American Urological Association, 2020 2020 Washington DC, USA

  13. Yoshida S, Taniguchi N, Moriyama S, Uehara S, Tanaka H, Kijima T, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Fujii Y. . Application of virtual reality in patient education about MRI-ultrasound fusion prostate biopsy.. The 35th Annual Congress of the European Association of Urology, 2020 2020 Amsterdam, Netherlands

  14. Uehara S, Matsuoka Y, Tanaka H, Moriyama S, Tanaka H, Kijima T, Yoshida Y, Yokoyama M, Ishioka J, Saito K, Fujii Y. Systematic biopsy cores near targets are of value for the detection of significant cancer: Analysis of prostate biopsy mapping using multiplanar MRI reconstruction.. The 12th international symposium on focal therapy and imaging in prostate and kidney cancer, 2020 2020 Washington DC, USA

  15. Uehara S, Matsuoka Y, Tanaka H, Moriyama S, Tanaka H, Kijima T, Yoshida Y, Yokoyama M, Ishioka J, Saito K, Fujii Y. Systematic biopsy cores apart from targets are of limited value for the detection of significant cancer: Analysis of prostate biopsy mapping using multiplanar MRI reconstruction. The 35th Annual Congress of the European Association of Urology, 2020 2020 Amsterdam, Netherlands

  16. Uehara S, Matsuoka Y, Tanaka H, Moriyama S, Tanaka H, Kijima T, Yoshida Y, Yokoyama M, Ishioka J, Saito K, Fujii Y. Systematic biopsy cores away from targets are of limited value for the detection of significant cancer: Analysis of 3D prostate biopsy mapping using multiplanar MRI reconstruction.. 114th annual meeting of the American Urological Association, 2020 2020 Washington DC, USA

  17. Toide M, Tanaka H, Uchida Y, Fukuda S, Fukushima H, Moriyama S, Uehara S, Kijima T, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Fujii Y. Stepwise diagnostic algorithm using CT and MRI for diagnosis of fat-poor angiomyolipoma in small renal masses: Prospective validation study. The 35th Annual Congress of the European Association of Urology, 2020 2020 Amsterdam, Netherlands

  18. Toide M, Tanaka H, Uchida Y, Fukuda S, Fukushima H, Moriyama S, Uehara S, Kijima T, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Fujii Y. Stepwise algorithm using CT and MRI for differential diagnosis of fat-poor angiomyolipoma in small renal masses: Prospective validation study. 114th annual meeting of the American Urological Association, 2020 2020 Washington DC, USA

  19. Moriyama S, Yokoyama M, Nakamura Y, Fukuda S, Fukushima H, Uehara S, Tanaka H, Kijima T, Yoshida S, Ishioka J, Matsuoka Y, Saito K, Fujii Y. Impact of nocturia on deteriorated renal function after adrenalectomy in patients with primary aldosteronism. 114th annual meeting of the American Urological Association, 2020 2020 Washington DC, USA

  20. Nakamura Y, Yokoyama M, Yoshida S, Tanaka H, Kijima T, Ishioka J, Matsuoka Y, Saito K, Minami I, Yoshimoto T, Naito S, Ogawa Y, Yamada T, Uchida S, Fujii Y. Postoperative renal impairment and longitudinal change in renal function after adrenalectomy in patients with Cushing’s syndrome. The 35th Annual European Association of Urology Congress Virtual, July 2020 2020

  21. Tanaka H, Shimada W, Fukuda S, Fukushima H, Moriyama S, Uehara S, Kijima T, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Campbell SC, Fujii Y. Significance of tumor shape irregularity for predicting potential oncologic risks in clinically localized renal cell carcinoma. The 114th Annual Meeting of the American Urological Association, 2020 (Virtual) 2020

  22. Tanaka H, Shimada W, Fukuda S, Fukushima H, Moriyama S, Uehara S, Kijima T, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Campbell SC, Fujii Y. Novel classification model of tumour shape irregularity: significance for predicting potential oncologic risks in clinically localised renal cell carcinoma. The 35th Annual Congress of the European Association of Urology, 2020 (Virtual) 2020

  23. Fukushima H, Kijima T, Uehara S, Tanaka H, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Matsubara N, Yuasa T, Masuda H, Yonese J, Kageyama Y, Fujii Y. Previous chemoradiotherapy may enhance the efficacy of pembrolizumab in advanced urothelial carcinoma patients. The 35th Annual Congress of the European Association of Urology 2020 Amsterdam, Netherlands

  24. Yokoyama M, Masuda H, Ito M, Waseda Y, Moriyama S, Toide M, Uchida Y, Uehara S, Tanaka H, Kijima T, Yoshida S, Ishioka J, Matsuoka Y, Saito K, Fujii Y. Longitudinal change in urinary incontinence, lower urinary tract symptoms and quality of life after artificial urinary sphincter implantation. 114th annual meeting of the American Urological Association 2020 Washington DC, USA

  25. Maruyama R, Fukushima H, Fukuda S, Moriyama S, Uehara S, Tanaka H, Kijima T, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Fujii Y. Low incidence of perioperative infections without antimicrobial prophylaxis in clean surgeries for adrenal and renal tumors: a prospective single-institutional study of 1339 patients. The 115th annual meeting of the American Urological Association 2020 Washington DC, USA

  26. Kato R, Fukushima H, Kijima T, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Otsuka Y, Koga F, Yano M, Tsukamoto T, Masuda H, Okuno T, Yonese J, Nagahama K, Kamata S, Noro A, Kageyama Y, Tsujii T, Morimoto S, Fujii Y. The qSOFA score outperforms the SIRS score in predicting in-hospital mortality of obstructive pyelonephritis patients: results from a multi-institutional study. The 115th annual meeting of the American Urological Association 2020 Washington DC, USA

  27. Fukushima H, Fukuda S, Moriyama S, Uehara S, Tanaka H, Kijima T, Yoshida S, Yokoyama M, Matsuoka Y, Saito K, Abe Y, Takemura Y, Fujii Y. Relationship between nocturia and whole-body fluid distribution assessed by bioelectrical impedance. The 115th annual meeting of the American Urological Association 2020

  28. Maruyama R, Fukushima H, Fukuda S, Moriyama S, Uehara S, Tanaka H, Kijima T, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Fujii Y. Feasibility of non-use of antimicrobial prophylaxis in clean urologic surgeries for adrenal and renal tumors: A prospective single-institutional study of 1339 patients. The 35th Annual Congress of the European Association of Urology 2020 Amsterdam Netherlands

  29. Kato R, Fukushima H, Kijima T, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Otsuka Y, Koga F, Yano M, Tsukamoto T, Masuda H, Okuno T, Yonese J, Nagahama K, Kamata S, Noro A, Kageyama Y, Tsujii T, Morimoto S, Fujii Y. Predictive performance of the qSOFA score for in-hospital mortality of obstructive pyelonephritis patients: A multi-institutional study. The 35th Annual Congress of the European Association of Urology 2020 Amsterdam, Netherlands

  30. Yoshida S., Tanaka H, Kijima T., Yokoyama M., Ishioka J., Matsuoka Y., Saito K., Kihara K., Fujii Y.. Vesical Imaging-Reporting And Data System (VI-RADS) for bladder cancer staging with multiparametric MRI.. 113th annual meeting of the American Urological Association 2019.05.06 Chicago, USA.

  31. Matsuoka Y, Tanaka H,Kimura T, Moriyama S, Uehara S, Yasuda Y, Kijima T, Yoshida S, Yokoyama M,Ishioka J, Saito K, Fujii Y.. Usefulness of apparent diffusion coefficient ratio between tumor andnontumor as an imaging biomarker for prostate cancer.. The 114th annual meeting of the AmericanUrological Association, 2019.05.06 Chicago, USA

  32. Kijima T., Teramatsu R., Fukuda S., Fukushima H.,Moriyama S., Uehara S., Yasuda Y., Yoshida S., Yokoyama M., Ishioka J.Matsuoka Y., Saito K., Fujii Y. ,. High levels of heat-shock factor 1 (HSF1) are associated with poor prognosisin muscle-invasive bladder cancer patients treated with chemoradiation-basedbladder sparing protocol.. 113th annual meeting of the American Urological Association 2019.05.04 Chicago, USA

  33. Fukushima H., Toide M., Fukuda S., Moriyama S., Yasuda Y., Uehara S., Kijima T., Yoshida S., Yokoyama M., Ishioka J., Matsuoka Y., Saito K., Fujii Y.. Impact of bladder neck involvement and positive urine cytology in substratifying intermediate-risk non-muscle-invasive bladder cancer patients based on the prediction of high-risk recurrence. . 113th annual meeting of the American Urological Association 2019.05.04 Chicago, USA

  34. Matsuoka Y, Uehara S, Yoshida S, Tanabe K, Tanaka H, Kimura T, Moriyama S,Yasuda Y, Kijima T, Yokoyama M, Ishioka J, Saito K, Fujii Y.. Who benefits additionally from concurrent systematic biopsy at the time ofMRI-ultrasound fusion targeted biopsy to detect significant prostate cancer?. The 114th annual meeting of the American Urological Association 2019.05.04 Chicago,USA

  35. 木島敏樹, 森山真吾, 福田翔平, 上原翔, 安田庸輔, 吉田宗一郎横山みなと, 石岡準一郎, 松岡陽, 齋藤一隆, 木原和徳, 藤井靖久.,. 副腎皮質癌の治療成績:再発例に対する集学的治療(化学療法、放射線療法、再発巣切除)の有効性. . 第107回日本泌尿器科学会総会 2019.04.18 名古屋

  36. Kijima T., Teramatsu R., Fukuda S., Fukushima H.,Moriyama S., Uehara S., Yasuda Y., Yoshida S., Yokoyama M., Ishioka J.,Matsuoka Y., Saito K., Fujii Y.. High levels of heat-shock factor 1 (HSF1) are associated with poor prognosis in muscle-invasive bladder cancer patients treated with chemoradiation-based bladder sparing protocol. . The 34th Annual Congress of the EuropeanAssociation of Urology 2019.03.18 Barcelona, Spain

  37. Fukushima H., Kijima T., Toide M., Fukuda S., Moriyama S., Yasuda Y., Uehara S., Yoshida S., Yokoyama M., Ishioka J., Matsuoka Y., Saito K., Kihara K., Fujii Y.. Tetra-modality bladder sparing therapy can be a viable treatment option for muscle-invasive bladder cancer patients with sarcopenia. . The 34th Annual Congress of the European Association of Urology 2019.03.18 Barcelona, Spain

  38. Fukushima H., Saito K., Yasuda Y., Uehara S., Kijima T., Yoshida S., Yokoyama M., Ishioka J., Matsuoka Y., Kihara K., Koga F., Okuno T., Arisawa C., Kamata S., Nagahama K., Masuda H., Yonese J., Kageyama Y., Noro A., Tsujii T., Morimoto S., Fujii Y. . Obesity-specific effect of sex on prognosis of upper urinary tract urothelial carcinoma patients undergoing radical nephroureterectomy: A Japanese multicenter study. . The 34th Annual Congress of the European Association of Urology 2019.03.18 Barcelona, Spain

  39. Fukushima H., Saito K., Yasuda Y., Tanabe K., Toide M., Fukuda S., Yokoyama M., Ishioka J., Matsuoka Y., Patil D., Cotta B., Patel S., Master V., Derweesh I., Fujii Y.. Impact of sex on prognosis of non-metastatic clear cell renal cell carcinoma patients undergoing curative surgery: An inverse probability of treatment weighting analysis. . The 34th Annual Congress of the European Association of Urology 2019.03.18 Barcelona, Spain

  40. Kijima T., Fukuda S., Fukushima H., Moriyama S., Uehara S., Yasuda Y.,Yoshida S., Yokoyama M., Ishioka J., Matsuoka Y., Saito K., Fujii Y.. Clinical outcomes of muscle-invasive bladder cancer patients withhydronephrosis treated with tetramodality bladder sparing therapyincorporating consolidative partial cystectomy. . The34th Annual Congress of the European Association of Urology, 2019.03.17 Barcelona, Spain

  41. Yoshida S., Takahara T., Ishii C., Nakagawa K., Toda K., Arita Y., Kijima T., Yokoyama M., Ishioka J., Matsuoka Y., Saito K., Yoshimura R., Fujii Y.. Loco-regional radiotherapy targeting oligo-progressive lesions in castration-resistant prostate cancer patients: Intra-pelvic localized progressive lesions are the good targets. . The 34th Annual Congress of the European Association of Urology 2019.03.17 Barcelona, Spain

  42. Uchida Y., Yoshida S., ShimodaH., TanakaH., SakamotoT., UeharaS., YasudaY.,KijimaT., YokoyamaM., IshiokaJ., MatsuokaY., SaitoK., Fujii Y.. Differentiation of chromophobe renal cell carcinoma and renal oncocytomawith whole-lesion ADC analysis on diffusion-weighted MRI. The 34th Annual Congress of the European Association of Urology 2019.03.17 Barcelona, Spain.

  43. Fukushima H., Toide M., Fukuda S., Moriyama S., Yasuda Y., Uehara S., Kijima T., Yoshida S., Yokoyama M., Ishioka J., Matsuoka Y., Saito K., Fujii Y.. Substratification of intermediate-risk non-muscle-invasive bladder cancer based on the prediction of high-risk recurrence: Impact of bladder neck involvement and positive urine cytology. . The 34th Annual Congress of the European Association of Urology 2019.03.17 Barcelona, Spain

  44. Kasumi Kaneko, Soichiro Yoshida, Yuki Arita, Kouhei Yamamoto, Toshiki Kijima, Minato Yokoyama, Junichiro Ishioka, Yoh Matsuoka, Kazutaka Saito, Yasuhisa Fujii. Renal epithelioid angiomyolipoma: Incidence in a Japanese cohort and diagnostic utility of diffusion-weighted MRI. The 34th Annual Congress of the European Association of Urology, 2019.03.17 Barcelona, Spain.

  45. Yoshida S., Tanaka H, Kijima T., Yokoyama M., Ishioka J., Matsuoka Y., Saito K., Kihara K., Fujii Y.. Vesical Imaging-Reporting And Data System (VI-RADS) for bladder cancer staging with multiparametric MRI.. The 34th Annual Congress of the European Association of Urology 2019.03.17 Barcelona, Spain.

  46. Matsuoka Y, Uehara S, Yoshida S, tanabe K, Tanaka H, KimuraT, Moriyama S, Yasuda Y, Kijima T, Yokoyama M, Ishioka J, Saito K, Fujii Y.. Who gains additional benefits from systematic biopsy concurrently performedwith MRI-ultrasound fusion targeted biopsy in the detection of significantprostate cancer?. he 34th Annual Congress of the European Association of Urology, 2019.03.16 Barcelona, Spain

  47. Kijima T., Fukuda S., Fukushima H., Moriyama S., Uehara S., Yasuda Y.. Clinical outcomes of muscle-invasive bladder cancer patients with. Genitourinary Cancers Symposium 2019.02.15 San Francisco, USA

  48. 木島敏樹、安田庸輔、上原翔、吉田宗一郎、横山みなと、石岡淳一郎、松岡陽、齋藤一隆、木原和徳、藤井靖久. 筋層浸潤膀胱癌に対する4者併用膀胱温存療法(TUR+低用量化学放射線療法+膀胱部分切除):Histologic variantを有する症例での検討.. 日本泌尿器腫瘍研究会第4回学術集会 2018.10.20 横浜

  49. 松岡 陽.. MRI超音波融合生検装置を使った前立腺がん診断と治療戦略.. 前立腺がん画像研究会 2018.09.21

  50. Kijima T., Prince T., Yoshida S., Yokoyama M, Ishioka J., Matsuoka. Novel therapy targeting androgen receptor splice variants by inhibiting heat. 112nd annual meeting of the American Urological Association 2018.05.20 San Francisco, USA

  51. Yasuda Y, Saito K, Soma T, Tanaka H, Kijima T, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Kihara K, Fujii Y. The outcome of gasless laparoscopic single-port clampless sutureless partial nephrectomy using three-dimensional head-mounted display. he outcome of gasless laparoscopic single-port clampless sutureless partial nephrectomy using three-dimensional head-mounted display. The 112th annual meeting of the American Urological Association 2018.05.18 San Francisco, USA

  52. Matsuoka Y, Ishioka J, Tanaka H, Kimura T, Waseda Y, Uehara S, Yasuda Y, Kijima T, Yoshida S, Yokoyama M, Saito K, Kihara K, Fujii Y. MRI-based risk assessment for postoperative biochemical recurrenceusing the Prostate Imaging Reporting and Data System (PI-RADS) scoresand capsular contact length. The 114th annual meeting of the American Urological Association 2018.05.18 San Francisco

  53. Junichiro Ishioka*, Yoh Matsuoka, Sho Uehara, Yosuke Yasuda, Toshiki Kijima, Soichiro Yoshida, Minato Yokoyama, Kazutaka Saito, Tomo Kimura, Kosei Kudo,Itsuo Kumazawa, Yasuhisa Fujii. Deep learning with a convolutional neural network algorithm for fully automated detection of prostate cancer using pre-biopsy MRI. 112th annual meeting of the American Urological Association 2018.05.18 San Francisco, USA

  54. Matsuoka Y, Tanaka H, Kimura T, Waseda Y, Uehara S, Yasuda Y, KijimaT, Yoshida S, Yokoyama M, Ishioka J, Saito K, Kihara K, Fujii Y. Clinical significance of MRI-targeted biopsy for the risk stratification of oncological outcome after radical prostatectomy. 第106回日本泌尿器科学会総会 2018.04.19 京都

  55. 木島 敏樹, 吉田 宗一郎, 横山みなと, 石岡 淳一郎, 松岡 陽, 齋藤 一隆, 木原 和徳, 藤井 靖久.. 熱ショック因子(Heat shock factor 1: HSF1)阻害によるARスプライスバリアントを標的とした去勢抵抗性前立腺癌に対する新規治療.. 第106回日本泌尿器科学会総会 2018.04.19 京都

  56. Waseda Y, Yoshida S, Takahara T, Arita Y, Sakamoto T, Yajima S, Uehara S, Yasuda Y, Tanaka H, Kijima T, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Kihara K, Fujii Y.. Feasibility of perfusion MRI to predict renal function after nephroureterectomy in upper tract urothelial carcinoma patients. The 33th European Association of Urology annual congress 2018.03.26 Copenhagen, Denmark

  57. Yajima S, Yoshida S, Takahara T,Arita Y, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Kihara K, Fujii Y. Absence of inchworm sign on DWI as a predictive marker for progression in pT1 bladder cancer. The 18th annual meeting of the European Association of Urology 2018.03.19 Copenhagen, Denmark

  58. Yoshida S., Takahara T., Ishii C., Arita Y., Kijima T., Yokoyama M., Ishioka J., Matsuoka Y., Saito K., Kihara K., Fujii Y. 935 METastasis Reporting And Data System for Prostate cancer (MET-RADS-P) score of whole-body DWI as a prognostic biomarker for castration-resistant prostate cancer. The 33th Annual Congress of the European Association of Urology 2018.03.19 Copenhagen, Denmark

  59. Yajima S, Yoshida S, Arita Y, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Kihara K, Fujii Y.. Absence of inchworm sign on DWI as a predictive marker for progression in pT1 bladder cancer. . 欧州泌尿器科学会(The 33th European Association of Urology annual congress, Copenhagen, Denmark) 2018.03.19 Copenhagen, Denmark

  60. Soma T, Yoshida S, Tanaka H, Uehara S, Yasuda Y, Kijima T, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Kihara K, Fujii Y. . The usefulness of diffusion-weighted MRI in the differential diagnosis of urachal disorders. . 欧州泌尿器科学会(The 33th European Association of Urology annual congress, Copenhagen, Denmark) 2018.03.19 Copenhagen, Denmark

  61. Kaneko K, Yoshida S, Takahara T, Sakamoto T, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Kihara K, Fujii Y. . Diffusion-weighted MRI as an imaging biomarker for histological grade of bladder cancer: Semi-automatic segmentation analysis. . 欧州泌尿器科学会(The 33th European Association of Urology annual congress, Copenhagen, Denmark) 2018.03.19 Copenhagen, Denmark

  62. Waseda Y, Yoshida S, Takahara T, Arita Y, Sakamoto T, Yajima S, Uehara S, Yasuda Y, Tanaka H, Kijima T, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Kihara K, Fujii Y.. Feasibility of perfusion MRI to predict renal function after nephroureterectomy in upper tract urothelial carcinoma patients.. 欧州泌尿器科学会(The 33th European Association of Urology annual congress, Copenhagen, Denmark) 2018.03.19 Copenhagen, Denmark

  63. Uehara S, Yoshida S, Matsuoka Y, Yasuda Y, Kijima T, Yokoyama M, Ishioka J, Saito K, Kihara K, Fujii Y. . Head-mounted display assisted magnetic resonance/ultrasound fusion prostate biopsy system.. 欧州泌尿器科学会(The 33th European Association of Urology annual congress, Copenhagen, Denmark) 2018.03.19 Copenhagen, Denmark

  64. Uehara S, Yoshida S, Tanaka H, Yasuda Y, Kijima T, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Kihara K, Fujii Y. . Prediction of intraoperative urinary collecting system entry in patients with peripheral renal tumors undergoing partial nephrectomy: Usefulness of tumor-centered multiplanar reconstruction.. 欧州泌尿器科学会(The 33th European Association of Urology annual congress, Copenhagen, Denmark) 2018.03.19 Copenhagen, Denmark

  65. Uehara S, Matsuoka Y, Tanaka H, Yasuda Y, Kijima T, Yoshida S, Yokoyama M, Ishioka J, Saito K, Kihara K, Fujii Y.. Do the Prostate Imaging Reporting and Data System scores reflect oncological outcome? Potential usefulness of scoring criteria-based assessment. . 欧州泌尿器科学会(The 33th European Association of Urology annual congress, Copenhagen, Denmark) 2018.03.19 Copenhagen, Denmark

  66. Yoshida S, Takahara T, Ishii C, Arita Y, Kijima T, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Kihara K, Fujii Y. . METastasis reporting and data system for prostate cancer score of whole-body DWI as a prognostic biomarker for castration-resistant prostate cancer. . 欧州泌尿器科学会(The 33th European Association of Urology annual congress, Copenhagen, Denmark) 2018.03.19 Copenhagen, Denmark

  67. Matsuoka Y, Tanaka H, Kimura T, Waseda Y, Uehara S, Yasuda Y, Kijima T, Yoshida S, Yokoyama M, Ishioka J, Saito K, Kihara K, Fujii Y.. Clinical significance of MRI-targeted biopsy in prediction of adverse pathological and oncological outcome after radical prostatectomy.. 欧州泌尿器科学会(The 33th European Association of Urology annual congress, Copenhagen, Denmark) 2018.03.19 Copenhagen, Denmark

  68. Matsuoka Y, Tanaka H, Kimura T, Waseda Y, Uehara S, Yasuda Y, Kijima T, Yoshida S, Yokoyama M, Ishioka J, Saito K, Kihara K, Fujii Y.. Clinical significance of MRI-targeted biopsy in prediction of adverse pathological and oncological outcome after radical prostatectomy.. 欧州泌尿器科学会(The 33th European Association of Urology annual congress, Copenhagen, Denmark) 2018.03.19 Copenhagen, Denmark

  69. Matsuoka Y, Tanaka H, Kimura T, Waseda Y, Uehara S, Yasuda Y, Kijima T, Yoshida S, Yokoyama M, Ishioka J, Saito K, Kihara K, Fujii Y.. Characteristics of global Gleason grading for MRI-targeted biopsy in comparison with systematic biopsy and prostatectomy grades.. 欧州泌尿器科学会(The 33th European Association of Urology annual congress, Copenhagen, Denmark) 2018.03.19 Copenhagen, Denmark

  70. Kaneko K, Yoshida S, Takahara T, Sakamoto T, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Kihara K, Fujii Y.. Diffusion-weighted MRI as an imaging biomarker for histological grade of bladder cancer: Semi-automatic segmentation analysis. . 欧州泌尿器科学会(The 33th European Association of Urology annual congress, Copenhagen, Denmark) 2018.03.19 Copenhagen, Denmark

  71. Kijima T, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Kihara K, Fujii Y. Favorable locoregional control in patients with histologic variants of urothelial carcinoma treated with tetra-modality bladder-sparing protocol incorporating consolidative partial cystectomy with lymph node dissection. . 欧州泌尿器科学会(The 33th European Association of Urology annual congress, Copenhagen, Denmark) 2018.03.18 Denmark

  72. Soma T, Ihioka J, Tanaka H, Uehara S, Yasuda Y, Kijima T, Yoshida S, Yokoyama M, Matsuoka Y, Saito K, Kihara K, Fujii Y. Computer-aided differential diagnosis of fat-poor angiomyolipoma using a deep neural networks algorithm in enhanced CT and T2-weighted magnetic resonance imaging. 欧州泌尿器科学会(The 33th European Association of Urology annual congress, Copenhagen, Denmark) 2018.03.17 Denmark

  73. Ishioka J, Matsuoka Y, Uehara S, Yasuda Y, Kijima T, Yoshida S, Yokoyama M, Matsuoka Y, Saito K, Kihara K, Kimura T, Kudo K, Kumazawa I, Fujii Y. Computer-aided diagnosis with a convolutional neural network algorithm for fully automated detection of prostate cancer using pre-biopsy MRI. 欧州泌尿器科学会(The 33th European Association of Urology annual congress, Copenhagen, Denmark) 2018.03.16 Denmark

  74. Yuma Waseda, Kazutaka Saito, Masaharu Inoue, Masaya Ito, Toshiki Kijima, Soichiro Yoshida, Minato Yokoyama, Junichiro Ishioka, Yoh Matsuoka, Kazunori Kihara, Yasuhisa Fujii. Predictive ability of renal cortex enhancement in dynamic CT for residual renal function after nephroureterectomy: Comparative study with renography.. AUA Annual Meeting 2017 2017.05.15 Boston

  75. Inoue M, Fujii Y, Ito M, Kijima T, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Kihara K.. Incidence and risk factors of postoperative hypertension after partial nephrectomy for renal tumors. AUA Annual Meeting 2017 2017.05.14 Boston

  76. Yuma Waseda, Masaharu Inoue, Masaya Ito, Toshiki Kijima, Soichiro Yoshida, Minato Yokoyama, Junichiro Ishioka, Yoh Matsuoka, Kazutaka Saito, Kazunori Kihara, Yasuhisa Fujii. New predictive scoring model for recurrence incorporating bladder neck involvement in patients with non-muscle-invasive bladder cancer.. AUA Annual Meeting 2017 2017.05.13 Boston

  77. Yosuke Yasuda1, Kazutaka Saito1, Naoko Kawamura1, Sho Uehara2, Takeshi Yuasa2, Minato Yokoyama1, Junichiro Ishioka1, Yoh Matsuoka1, Shinya Yamamoto2, Shunji Takahashi3, Tetsuo Okuno4, Junji Yonese2, Kazunori Kihara1 and Yasuhisa Fujii1. EARLY RESPONSE AT FOUR WEEKS OF C-REACTIVE PROTEIN PREDICTS SURVIVAL IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA TREATED WITH TYROSINE KINASE INHIBITORS. 2017.05.12 Boston

  78. 井上雅晴,井靖久,藤将也,木島敏樹,田宗一郎,横山みなと,石岡淳一郎,松岡 陽,齋藤一隆,木原和徳. 腎部分切除後の高血圧発症・増悪およびそのリスク因子. 第105回日本泌尿器科学会総会 2017.04.21 鹿児島

  79. 田中一,吉田宗一郎,井上雅晴,伊藤将也,木島敏樹,横山みなと,石岡淳一郎,松岡陽,齋藤一隆,木原和徳,藤井靖久. 膀胱癌の免疫組織化学染色に基づく分子サブタイプ分類と化学放射線療法感受性及び予後の解析:筋層浸潤膀胱癌に対する新たな治療戦略に向けて. 第105回日本泌尿器科学会総会 2017.04.21 鹿児島

  80. 川村尚子,横山みなと,中山貴之,田中一,井上雅晴,伊藤将也,木島敏樹,吉田宗一郎,石岡淳一郎,松岡陽,齋藤一隆,木原和徳,藤井靖久. 無阻血腎部分切除後の急性腎障害:発生率と術後腎機能への影響. 第105回日本泌尿器科学会総会 2017.04.21 鹿児島、日本

  81. 吉田宗一郎、高原太郎、石井千佳子、田中一、井上雅晴、伊藤将也、木島敏樹、横山みなと、石岡淳一郎、松岡陽、齋藤一隆、木原和徳、藤井靖久. DWIBS法による全身拡散強調MRIを用いた去勢抵抗性前立腺癌の予後評価. 第105回日本泌尿器科学会総会 2017.04.21 鹿児島

  82. Matsuoka Y, Tanaka H, Kimura T, Ito M, Inoue M, Kijima T, Yoshida S,. MRI-targeted biopsy vs. systematic biopsy in prediction of biochemical recurrence after radical prostatectomy. 第105回日本泌尿器科学会総会 2017.04.21 Kagoshima

  83. Nakamura Yuki, Tanaka Hajime, Fujii Yasuhisa, Inoue Masaharu, Ito Masaya, Kijima Toshiki, Yoshida Soichiro, Yokoyama Minato, Ishioka Junichiro, Matsuoka Yoh, Saito Kazutaka, Kihara Kazunori. Bladder-sparing protocol consisting of low-dose chemoradiotherapy and consolidative partial cystectomy against muscle-invasive bladder cancer: A comparison of oncological outcomes between primary and progressive diseases. . 32nd Annual EAU Congress 2017.03.27 London, UK

  84. Matsuoka Y, Ishioka J, Tanaka H, Kimura T, Inoue M, Ito M, Kijima T, Yoshida. Characteristics of MRI staging using PI-RADS version 2 and its predictive performance for biochemical recurrence after radical prostatectomy compared to PI-RADS version 1. 32nd Annual EAU Congress 2017.03.27 London

  85. N. Kawamura, K. Saito, M. Inoue, M. Ito, T. Kijima, S. Yoshida,M. Yokoyama, J. Ishioka, Y. Matsuoka, K. Kihara, Y. Fujii. Adherent perinephric fat in Asian patients: predictors, andimpact on perioperative outcomes of partial nephrectomy. 32nd Annual EAU Congress 2017.03.27 London、England

  86. N. Kawamura, M. Yokoyama, T. Nakayama, H. Tanaka, M. Inoue, M.Ito, T. Kijima, S. Yoshida, J. Ishioka, Y. Matsuoka, K. Saito, K. Kihara,Fujii Y.. Acute kidney injury after clampless partial nephrectomy:incidence, predictors, and its low impact on intermediate-term renalfunction . 32nd Annual EAU Congress 2017.03.27 London、England

  87. Matsuoka Y, Saito K, Numao N, Tanaka H, Inoue M, Ito M, Yoshida S, Yokoyama M, Ishioka J, Fujii Y, Kihara K. Risk assessment for undertreatment in focal therapy and its applicability to intermediate- and high-risk prostate cancer. 9th International Symposium on Focal Therapy and Imaging in prostate & kidney cancer 2016.06.23 Durham, USA

  88. Saito K, Matsuoka Y, Numao N, Hayashi K, Toda K, Ito M, Inoue M, Yoshida S, Yokoyama M, Ishioka J, Fujii Y, Yoshimura R, Kihara K. Hemi-gland brachytherapy for localized prostate cancer. 9th International Symposium on Focal Therapy and Imaging in prostate & kidney cancer 2016.06.23 Durham, USA

  89. Matsuoka Y, Ishioka J, Tanaka H, Inoue M, Ito M, Yoshida S, Yokoyama M, Numao N, Saito K, Fujii Y, Kihara K. Impact of the Prostate Imaging Reporting and Data System version 2 (PI-RADS v2) on the assessment of extracapsular extension in prostate cancer: A multireader study.. 米国泌尿器科学会(annual meeting of the American Urological Association) 2016.05.09 San Diego, USA

  90. 13.Nakayama T, Kazutaka S, Fujii Y, Waseda Y, Moriyama S, Tanaka H, Kawamura N, Inoue M, Ito M, Yoshida, S, Yokoyama M, Matsuoka Y, Numao N, Kihara K. Association of M2 macrophage invasion with C-reactive protein in renal cell carcinoma.. 米国泌尿器科学会(annual meeting of the American Urological Association) 2016.05.09 San diego, USA

  91. Moriyama S et al. MRI intensity ratio curve analysis: a new objective method for characterizing small renal masses.. 米国泌尿器科学会(annual meeting of the American Urological Association) 2016.05.09 San diego, USA

  92. Masaharu Inoue, Fumitaka Koga, Soichiro Yoshida, Hajime Tanaka, Shuichiro Kobayashi, Minato Yokoyama, Junichiro Ishioka, Yoh Matsuoka, Noboru Numao, Kazutaka Saito, Yasuhisa Fujii, Kazunori Kihara. Predictive model for therapeutic resistance using ERBB2 expression status and Ki-67 labeling index in muscle-invasive bladder cancer patients treated with chemoradiotherapy-based bladder-sparing protocol. AUA2016 Annual Meeting 2016.05.09 San Diego, USA

  93. Matsuoka Y, Ishioka J, Tanaka H, Nakayama T, Inoue M, Ito M, Yoshida S, Yokoyama M, Numao N, Saito K, Fujii Y, Kihara K. Impact of prebiopsy magnetic resonance imaging (MRI) on preoperative risk stratification for biochemical recurrence after radical prostatectomy. . 米国泌尿器科学会(annual meeting of the American Urological Association) 2016.05.08 San Diego, USA

  94. Ishioka J et al. Prognostic impact of C-reactive protein kinetics on survival of patients with advanced urothelial carcinoma. A multicenter study. . 米国泌尿器科学会(annual meeting of the American Urological Association) 2016.05.08 San diego, USA

  95. Fujii Y et al.. Bladder-sparing protocol consisting of low-dose chemoradiotherapy and consolidative partial cystectomy against muscle-invasive bladder cancer: Comparison of oncological and functional outcomes between older and younger patients. 米国泌尿器科学会(annual meeting of the American Urological Association) 2016.05.08 USA

  96. 8.Ishioka J et al. Yokoyama M., Kawamura N., Fujii Y., Inoue M., Ishioka J., Numao N., Matsuoka Y., Saito K., Arisawa C., Okuno T., Noro A., Morimoto S., Kihara K.. Longitudinal renal function recovery after radical nephrectomy and risk factors for postoperative severe renal impairment: a Japanese multicenter study.. 米国泌尿器科学会(annual meeting of the American Urological Association) 2016.05.08 San diego, USA

  97. Yoshida S et al. . Apparent diffusion coefficient as a prognostic biomarker of upper urinary tract cancer.. 米国泌尿器科学会(annual meeting of the American Urological Association) 2016.05.07 San diego, USA

  98. Kobayashi M et al. Maximum standardized uptake value of 18F-FDG PET/CT predicts survival of patients with advanced urothelial carcinoma. 米国泌尿器科学会(annual meeting of the American Urological Association) 2016.05.07 San diego, USA

  99. Tanaka H et al. Development and validation of a novel stepwise algorithm using CT and MRI for diagnosis of fat-poor angiomyolipoma in small renal masses. . 米国泌尿器科学会(annual meeting of the American Urological Association) 2016.05.07

  100. Ito M et al. Likelihood of underlying Lynch syndrome in Japanese upper tract urothelial carcinoma patients. 米国泌尿器科学会(annual meeting of the American Urological Association) 2016.05.07 San diego, USA,

  101. Matsuoka Y, Numao N, Saito K, Tanaka H, Inoue M, Ito M, Yoshida S, Yokoyama M, Ishioka J, Fujii Y, Kihara K. Applicability analysis of focal therapy to intermediate- and high-risk prostate cancer. . 米国泌尿器科学会(annual meeting of the American Urological Association) 2016.05.06 San Diego, USA

  102. Ishioka J et al.. The incidence of late bladder tumor recurrence of upper tract urothelial carcinoma and optimal cystoscopic follow-up: A multicenter study.. 米国泌尿器科学会(annual meeting of the American Urological Association) 2016.05.06 San diego, USA

  103. Numao N et al. Optimal combination of MRI-targeted biopsy and systematic biopsy for men with suspicion of prostate cancer. . 米国泌尿器科学会(annual meeting of the American Urological Association) 2016.05.06 San diego, USA

  104. Nakamura Y et al.. Masked renal dysfunction in patients with adrenal Cushing's syndrome manifested by adrenalectomy. 米国泌尿器科学会(annual meeting of the American Urological Association 2016.05.06 San diego, USA

  105. Nakamura Y et al. . High specificity of diffusion-weighted MRI in differentiating residual bladder cancer from postoperative changes. 米国泌尿器科学会(annual meeting of the American Urological Association 2016.05.06 San diego, USA

  106. Matsuoka Y, Ishioka J, Tanaka H, inoue M, Ito M, Yoshida S, Yokoyama M, Numao N, Saito K, Fujii Y, Kihara K. Impact of PI-RADS version 2 on MRI diagnosis for extracapsular extension of prostate cancer: A multireader study. 欧州泌尿器科学会(European Association of Urology annual congress) 2016.03.14 Munich, Germany

  107. 14.Yasuda Y, Saito K, Kawamura N, Yuasa T, Yokoyama M, Matsuoka Y, Ishioka J, Numao N, Okuno T, Yamamoto S, Takahashi S, Yonese J, Fujii Y, Kihara K. Prognostic significance of early CRP response for metastatic renal cell carcinoma treated with tyrosine kinase inhibitor. 欧州泌尿器科学会(European Association of Urology annual congress) 2016.03.14 Germany

  108. Inoue M et al. . Prediction of therapeutic resistance using ERBB2 expression status and Ki-67 labelling index in muscle-invasive bladder cancer patients treated with chemoradiation-based selective bladder-sparing approach. . 欧州泌尿器科学会(European Association of Urology annual congress) 2016.03.14 Munich, Germany

  109. Yoshida S et al. The utility of diffusion-weighted MRI as an imaging biomarker of upper urinary tract cancer: A preoperative prognostic indicator reflecting histological grade. . 欧州泌尿器科学会(European Association of Urology annual congress) 2016.03.14 Munich, Germany

  110. 4.Kawamura N, Yokoyama M, Fujii Y, Inoue M, Ito M, Yoshida S, Ishioka J, Numao N, Matsuoka Y, Saito K, Kihara K.. Longitudinal preservation of renal function after clamp-less partial nephrectomy: An analysis of patients with chronic kidney disease.. 欧州泌尿器科学会(European Association of Urology annual congress) 2016.03.14 Germany

  111. Masaharu Inoue, Fumitaka Koga, Soiciro Yoshida, Hajime Tanaka, Shuichiro Kobayashi, Masaya Ito, Minato Yokoyama, Junichiro Ishioka, Yoh Matsuoka, Noboru Numao, Kazutaka Saito, Yasuhisa Fujii, Kazunori Kihara. Prediction of therapeutic resistance using ERBB2 expression status and Ki-67 labeling index in muscle-invasive bladder cancer patients treated with chemoradiation-based selective bladder-sparing approach. the 31st Annual EAU Congress 2016.03.14

  112. 1.Fujii Y, Kihara K, Tanaka H, Saito K., Yoshida S, Yokoyama M., Ishioka J, Matsuoka Y, Numao N. . Bladder-sparing protocol consisting of ow-dose chemoradiotherapy and consolidative partial cystectomy against muscle-invasive bladder cancer: Oncological and functional outcome in elderly patients.. 欧州泌尿器科学会(European Association of Urology annual congress) 2016.03.13 Germany

  113. Nakamura Y et al. Renal dysfunction manifestation in patients with adrenal Cushing's syndrome after adrenalectomy. 欧州泌尿器科学会(European Association of Urology annual congress) 2016.03.13 Munich, Germany

  114. Moriyama S et al. A new quantitative method for characterizing small renal masses: MRI intensity ratio curve analysis. 欧州泌尿器科学会(European Association of Urology annual congress) 2016.03.13 Munich, Germany

  115. 5.Yokoyama M, Kawamura N, Fujii Y, Inoue M, Ishioka J, Numao N, Matsuoka Y, Saito K, Arisawa C, Okuno T, Noro A, Morimoto S, Kihara K. . Longitudinal changes in renal function after radical nephrectomy and risk factors for postoperative severe renal impairment: A Japanese multicenter study using a linear mixed model analysis. 欧州泌尿器科学会(European Association of Urology annual congress) 2016.03.13 Germany

  116. Waseda Y. et al.. Elevation of urinary metanephrine/normetanephrine and impairment of glucose tolerance predict the development of hypoglycemia after resection of pheochromocytoma. 欧州泌尿器科学会(European Association of Urology annual congress) 2016.03.13

  117. Ishioka J et al. When should patients undergo prostate biopsy? Decision analysis using differences in the health-related quality-of-life between pre-biopsy healthy men and patients with castration-resistant prostate cancer. . 欧州泌尿器科学会(European Association of Urology annual congress) 2016.03.12 Munich, Germany

  118. Fujiwara M et al.. Antibiotic prophylaxis is avoidable in minimally invasive clean surgery for renal or adrenal tumors: A prospective study of 678 cases. Munich, Germany 2016.03.12 Munich, Germany

  119. Tanaka H et al. Novel stepwise algorithm using CT and MRI for differential diagnosis of fat-poor angiomyolipoma in small renal masses: Development and external validation. . 欧州泌尿器科学会(European Association of Urology annual congress) 2016.03.12 Munich, Germany

  120. Yoshida S et al. . Potential utility of standardized apparent diffusion coefficient value as a biomarker predicting clinical aggressiveness of bladder cancer with various MRI protocols at various institutions. . 欧州泌尿器科学会(European Association of Urology annual congress) 2016.03.12 Munich, Germany

  121. Matsuoka Y, Numao N, Saito K, Tanaka H, Ito M, Yoshida S, Yokoyama M, Ishioka J, Fujii Y, Kihara K. Eligibility analysis for focal therapy based on prostatectomy findings: Does intermediate-risk cancer have a higher likelihood of undertreatment than low-risk cancer?. 8th International Symposium on Focal Therapy and Imaging in Prostate & Kidney Cancer 2015.06.21 Amsterdam, Netherland

  122. Saito K, Matsuoka Y, Numao N, Hayashi K, Yoshida S, Yokoyama M, Ishioka J, Fujii Y, Yoshimura R, Kihara K. Focal therapy for prostate cancer with hemi-gland low dose rate brachytherapy. 8th International Symposium on Focal Therapy and Imaging in Prostate & Kidney Cancer 2015.06.21 Amsterdam, Netherland

  123. Numao N, Ito M, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Fujii Y, Kihara K. Efficient sampling methods in systematic biopsy that could be performed in combination with MRI-guided biopsy. 8th International Symposium on Focal Therapy and Imaging in Prostate & Kidney Cancer 2015.06.21 Amsterdam, Netherland

  124. Fujii Y., Kihara K., Tanaka H., Tatokoro M., Yoshida S.m Yokoyama M., Ishioka J., Matusoka Y., Numao N., Saito K. Oncological and functional outcomes in muscle-invasive bladder cancer patients undergoing bladder-sparing treatment consisting of low-dose chemoradiotherapy and consolidative partial cystectomy. The 111th annual meeting of the American Urological Association 2015.05.18 New Orleans, USA

  125. 1.Kawamura N., Yokoyama M., Fujii Y., Ishioka J., Numao N., Matsuoka Y., Saito K, Arisawa C., Okuno T., Noro A., Morimoto S., Kihara K. Recovery in renal function after radical nephrectomy and its negative predictive factors: a multicenter longitudinal study. The 111th annual meeting of the American Urological Association 2015.05.18 New Orleans, USA

  126. Numao N., Ito M., Uchida Y., Yoshida S., Nakayama T., Inoue M., Tatokoro M., Yokoyama M., Ishioka J., Matsuoka Y., Saito K., Fujii Y., Kihara K. Optimal MRI-targeted biopsy sampling number. The 111th annual meeting of the American Urological Association 2015.05.17

  127. Yoshida S., Fukuyo T., Ito M., Tatokoro M., Ishioka J., Matsuoka Y., Numao N., Saito K., Fujii Y., Kihara K. Development of new three-dimensional image system for transurethral surgery. The 111th annual meeting of the American Urological Association 2015.05.16 New Orleans, USA

  128. 7.Moriyama S., Saito K., Ishioka J., Kageyama Y., Morimoto S., Arisawa C., Ito M., Tatokoro M., Yoshida S., Yokoyama M., Matsuoka Y., Numao N., Fujii Y., Kihara K. Preoperative selection algorithm for eligible neoadjuvant chemotherapy patients in upper tract urothelial carcinomas. The 111th annual meeting of the American Urological Association 2015.05.15 New Orleans, USA

  129. Tatokoro M., Nakanishi Y., Komai Y., Matsuoka Y., Ishioka J., Numao N., Yoshimoto K., Saito K., Fujii Y., Ogawa Y., Kihara K. Impact of impaired glucose tolerance on the development of hypoglycemia following removal of pheochromocytoma. 111th annual meeting of the American Urological Association 2015.05.15 New Orleans, USA

  130. Tanaka H., Fujii Y., Ito M., Tatokoro M., Yoshida S., Yokoyama M., Ishioka J., Matsuoka Y., Numao N., Saito K., Yonese J., Kihara K. Development and validation of a novel prediction model for fat-poor angiomyolipoma in small renal masses based on radiological and clinical features. The 111th annual meeting of the American Urological Association 2015.05.15 New Orleans, USA

  131. 2.Ishioka J, Yokoyama M, Waseda Y,Kawamura N, Itoh M, Tatokoro M, Yoshida S, Matsuoka Y,Numao N, Saito K, Arisawa C, Morimoto S, Kageyama Y,Fujii Y, Kihara K. Preoperative prediction of postoperative renal function for upper tract urothelial carcinoma patients: Concerning issues of perioperative renal impairment and the use of cisplatin-based chemotherapy. The 30th Annual Congress of the European Association of Urology 2015.03.23 Madrid, Spain

  132. 3.Kawamura N., Yokoyama M., Fujii Y., Ishioka J., Numao N., Matsuoka Y., Saito K, Arisawa C., Okuno T., Noro A., Morimoto S., Kihara K. Longitudinal change and risk factors of severe deterioration in renal function after radical nephrectomy. The 30th Annual Congress of the European Association of Urology 2015.03.23 Madrid, Spain

  133. Yoshida S., Fukuyo T., Ito M., Tatokoro M., Yokoyama M, Ishioka J., Matsuoka Y., Numao N., Saito K., Fujii Y., Kihara K. A novel three-dimensional image display system for transurethral surgery. The 30th Annual Congress of the European Association of Urology 2015.03.23 Madrid, Spain

  134. 8.Nakamura Y. , Numao N. , Yoshida S. , Komai Y. , Ito M. , Tatokoro M. , Yokoyama M. , Ishioka J. , Matsuoka Y. , Saito K. , Fujii Y. , Kihara K.. Transrectal 12-core prostate biopsy and MRI have a comparable risk of missing significant prostate cancer in men with PSA less than 10ng/ml and normal DRE. The 30th Annual Congress of the European Association of Urology 2015.03.23 Madrid, Spain

  135. 14.Fujii, Y., Kihara, K., Numao, N., Tanaka H., Tatokoro M., Yoshida S., Yokoyama M., Ishioka J., Matsuoka Y., Numao N., Saito K. Selective bladder-sparing protocol consisting of low-dose chemoradiotherapy and consolidative partial cystectomy against muscle-invasive bladder cancer: oncological and functional outcome. The 30th Annual Congress of the European Association of Urology 2015.03.22 Madrid, Spain

  136. 5.Tanaka H, Fujii Y, Ito M, Tatokoro M, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Numao N, Saito K, Yonese J, Kihara K. Novel prediction model for fat-poor angiomyolipoma in small renal masses based on radiological and clinical features. The 30th Annual Congress of the European Association of Urology 2015.03.22 Madrid, Spain

  137. 13.Fujii, Y., Kihara, K., Numao, N., Matsuoka, Y., Ishioka, J., Saito, K. Gasless single-port RoboSurgeon partial cystectomy: A hybrid technique combining an intravesical and extravesical approach. The 30th Annual Congress of the European Association of Urology 2015.03.22

  138. 7.Moriyama S., Saito K., Ishioka J., Kageyama Y., Morimoto S., Arisawa C., Ito M., Tatokoro M., Yoshida S., Yokoyama M., Matsuoka Y., Numao N., Fujii Y., Kihara K. Preoperative prediction algorithm for the selection of candidates for neoadjuvant chemotherapy in upper tract urothelial carcinomas. The 30th Annual Congress of the European Association of Urology 2015.03.22 Madrid, Spain

  139. 6.Tatokoro M., Nakanishi Y., Komai Y., Matsuoka Y., Ishioka J., Numao N., Yoshimoto K., Saito K., Fujii Y., Ogawa Y., Kihara K. Impaired glucose tolerance predicts the development of hypoglycemia after removal of pheochromocytoma. The 30th Annual Congress of the European Association of Urology 2015.03.22 Madrid, Spain

  140. 10.Numao N., Ito M., Uchida Y., Yoshida S., Nakayama T., Inoue M., Tatokoro M., Yokoyama M., Ishioka J., Matsuoka Y., Saito K., Fujii Y., Kihara K. Optimal number of sampling cores in MRI-targeted biopsy, Madrid. The 30th Annual Congress of the European Association of Urology 2015.03.21 Madrid, Spain

  141. Masaharu Inoue, Yasuhisa Fujii, Minato Yokoyama, Masaya Ito, Manabu Tatokoro, Soichiro Yoshida, Junichiro Ishioka, Yoh Matsuoka, Noboru Numao, Kazutaka Saito, Kazunori Kihara. Progression of hypertension after partial nephrectomy in Japanese patients with renal tumors. 30th Annual EAU Congress 2015.03.21 Madrid, Spain

  142. 9.Nakayama T., Saito K., Fujii Y., Ito M., Tatokoro M., Yoshida S., Yokoyama M., Ishioka J., Matsuoka Y., Numao N, Kihara K. Prognostic comparison of serum biomarkers for cancer-specific survival of renal cell carcinoma undergoing nephrectomy: C-reactive protein has the highest predictive ability on survival. The 30th Annual Congress of the European Association of Urology 2015.03.21

  143. Matsuoka Y, Numao N, Saito K, Tanaka H, Kijima T, Nakanishi Y, Yoshida S, Ishioka J, Fujii Y, Kihara K. Topographical risk stratification of undertreatment in focal therapy for prostate cancer: Mid-apical biopsy compensates for MRI underdiagnosis. The 29th Annual Congress of the European Association of Urology 2014.04.13 Stockholm

  144. Matsuoka Y, Numao N, Saito K, Tanaka H, Yoshida S, Yokoyama M, Ishioka J, Koga F, Masuda H, Fujii Y, Kihara K. Quadrant-ablation focal therapy of prostate cancer: candidate selection through a combination of extended biopsy and MRI. 6th International Symposium on Focal Therapy and Imaging in Prostate & Kidney Cancer 2013.05.29 Amsterdam

  145. Matsuoka Y, Numao N, Saito K, Tanaka H, Yoshida S, Yokoyama M, Ishioka J, Koga F, Masuda H, Fujii Y, Kihara K. Combination of extended biopsy and MRI identifies candidates for quadrant-ablation focal therapy of prostate cancer. The 107th annual meeting of the American Urological Association 2013.05.06 San Diego

  146. Matsuoka Y, Ishioka J, Numao N, Tanaka H, Yoshida S, Yokoyama M, Koga F, Saito K, Masuda H, Fujii Y, Kihara K. Impact of MRI on the prediction of side-specific extracapsular extension: Nomogram based on tumor contact length and percent positive biopsy cores. The 107th annual meeting of the American Urological Association 2013.05.05 San Diego

  147. Matsuoka Y, Numao N, Saito K, Tanaka H, Yoshida S, Yokoyama M, Ishioka J, Koga F, Masuda H, Fujii Y, Kihara K. Candidate selection for quadrant-ablation focal therapy of prostate cancer through a combination of extended 14-core biopsy and MRI. The 28th Annual Congress of the European Association of Urology 2013.03.17 Milan

  148. Matsuoka Y, Ishioka J, Numao N, Tanaka H, Yoshida S, Yokoyama M, Koga F, Saito K, Masuda H, Fujii Y, Kihara K. Simple prediction model of side-specific extracapsular extension based on percent positive biopsy cores and tumor contact length with the capsule on MRI. The 28th Annual Congress of the European Association of Urology 2013.03.17 Milan

  149. Matsuoka Y, Numao N, Saito K, Tanaka H, Kijima T, Kobayashi S, Tatokoro M, Sakura M, Yokoyama M, Ishioka J, Koga F, Masuda H, Kihara K. Combination of 14-core biopsy and magnetic resonance imaging can identify appropriate candidates for hemiablative focal therapy of prostate cancer. The 106th annual meeting of the American Urological Association 2012.05.20 Atlanta

  150. Matsuoka Y, Numao N, Saito K, Tanaka H, Kijima T, Kobayashi S, Tatokoro M, Sakura M, Yokoyama M, Ishioka J, Koga F, Masuda H, Kihara K. Candidate selection for hemiablative focal therapy of prostate cancer through a combination of extended 14-core biopsy and MRI. The 27th Annual Congress of the European Association of Urology 2012.02.25 Paris

  151. Matsuoka Y, Masuda H, Yokoyama M, Yoshida S, Kihara K. Bilirubin Attenuates Cyclophosphamide-induced Cystitis in Rats. 29th Congress of the Societe Internationale d'Urologie 2007.09.03 Paris

  152. Matsuoka Y, Masuda H, Yokoyama M, Kihara K. Heme Oxygenase-1 Attenuates Cyclophosphamide-induced Cystitis in Rats. The 22nd Annual Congress of the European Association of Urology 2007.03.22 Berlin

  153. Matsuoka Y, Kobayashi T, Nagahama Y. Cloning of Protein Kinases from Mature Testes of a Teleost Fish, Tilapia. 9th International Symposium on Spermatology 2002.10.08 Cape Town

▼display all

Awards & Honors 【 display / non-display

  • 3rd prize of best poster award,International Symposium on Focal Therapy and Imaging in Prostate & Kidney Cancer,2015.06

  • IJU Reviewers of the Year 2013,International Journal of Urology,2014.04

  • Best Poster Presentation,The 27th Annual Congress of the European Association of Urology,2012.02

 

Performance of duties 【 display / non-display

  • ,2011.05 - 2014.11